BioGrowing Co., Ltd
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Oral Lactobacillus Crispatus Lc-G22 as Adjunctive Therapy for Vulvovaginal Candidiasis (NCT07727967) | BioGrowing Co., Ltd | 2022-07-01 |
Track BioGrowing Co., Ltd automatically
Every clearance here is in the API, with alerts when new ones post.